GENERATE BIOMEDICINES INC

Historical 13F Holders

Symbol
GENB
CUSIP
370920100
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 370920100 since 12/18/2024, largest first.

Filer % of Class Filed
Flagship Pioneering, LLC 13G
48.9% 5/15/2026
Event 3/31/2026
Nally Michael 13G 5.2% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 58.0 $871.00
2026 Q2 87 100 M $1.69 B
2026 Q1 58 92.8 M $1.16 B